Executive Summary
Omega Diagnostics Group was established in September 2006 when Omega Diagnostics Ltd completed a “reverse acquisition” of an AIM Listed cash shell company called Quintessentially English PLC. Omega sells a wide range of immunoassay-based products in the in-vitro diagnostics (IVD) market, through a strong distribution network in over 100 countries.
Company History
Current Events
Business Model
Products/Services
Segments/Customers
Production/Operations
Distribution/Routes to Market
Market & Competition
Market Share
Main Competitors
Competitive Strengths and Weaknesses
Management
Financials
Profit & Loss
Balance sheet
Cashflow
Valuation
Comparable Companies
SWOT Analysis
Strengths
Weaknesses
Opportunities
Threats
